The Hydration Pharmaceuticals Company Ltd (HPC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.606x

Based on the latest financial reports, The Hydration Pharmaceuticals Company Ltd (HPC) has a cash flow conversion efficiency ratio of -0.606x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.64 Million ≈ $-1.16 Million USD) by net assets (AU$2.71 Million ≈ $1.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of The Hydration Pharmaceuticals Company Lt to measure how much of total assets are equity-financed.

The Hydration Pharmaceuticals Company Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how The Hydration Pharmaceuticals Company Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check The Hydration Pharmaceuticals Company Lt (HPC) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

The Hydration Pharmaceuticals Company Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of The Hydration Pharmaceuticals Company Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Diamcor Mining V:DMI	-0.005x
Gossan Resources Ltd V:GSS	-0.099x
Value Management & Research AG F:VMR1	0.239x
GLOBAL HELIUM CORP. F:5P0	N/A
New Star Investment Trust plc LSE:NSI	0.009x
MPAC Group PLC LSE:MPAC	-0.028x
Mpower Group Ltd AU:MPR	0.069x
Jaxon Mining Inc V:JAX	0.002x

Annual Cash Flow Conversion Efficiency for The Hydration Pharmaceuticals Company Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see HPC stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$2.74 Million ≈ $1.94 Million	AU$-3.02 Million ≈ $-2.14 Million	-1.101x	-106.89%
2023-12-31	AU$-358.25K ≈ $-253.49K	AU$-5.73 Million ≈ $-4.05 Million	15.993x	+752.93%
2022-12-31	AU$3.98 Million ≈ $2.82 Million	AU$-9.75 Million ≈ $-6.90 Million	-2.449x	-301.06%
2021-12-31	AU$13.23 Million ≈ $9.36 Million	AU$-8.08 Million ≈ $-5.72 Million	-0.611x	+68.33%
2020-12-31	AU$2.00 Million ≈ $1.42 Million	AU$-3.86 Million ≈ $-2.73 Million	-1.928x	-69.48%
2019-12-31	AU$2.44 Million ≈ $1.73 Million	AU$-2.78 Million ≈ $-1.97 Million	-1.138x	+43.84%
2018-12-31	AU$2.66 Million ≈ $1.88 Million	AU$-5.40 Million ≈ $-3.82 Million	-2.026x	--

About The Hydration Pharmaceuticals Company Ltd

AU:HPC Australia Food Distribution

Market Cap

$1.22 Million

AU$1.72 Million AUD

Market Cap Rank

#30436 Global

#1786 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.36